Pre-treatment 18F-FDG PET/CT parameters in non-small-cell lung cancer patients treated with stereotactic radiotherapy

被引:0
|
作者
Bernhardt, D. [1 ,2 ,3 ]
Asai, K. [4 ]
Ogha, S. [4 ]
Baba, S. [4 ]
Kamitani, T. [4 ]
Maruoka, Y. [4 ]
Yoshiki, A. [4 ]
Rieken, S. [2 ,5 ]
Debus, J. [1 ,2 ,3 ]
Honda, H. [6 ]
机构
[1] Univ Klinikum Heidelberg, Radioonkol & Strahlentherapie, Heidelberg, Germany
[2] HIRO, Heidelberg, Germany
[3] Heidelberg Ion Beam Therapy Ctr HIT, Heidelberg, Germany
[4] Kyushu Univ, Dept Clin Radiol, Fukuoka, Japan
[5] Univ Klinikum Heidelberg, Heidelberg, Germany
[6] Kyushu Univ, Dept Clin Radiol, Fukuoka, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P17-9-jD
引用
收藏
页码:S146 / S147
页数:2
相关论文
共 50 条
  • [21] 18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy
    Evangelista, Laura
    Cuppari, Lea
    Menis, Jessica
    Bonanno, Laura
    Reccia, Pasquale
    Frega, Stefano
    Pasello, Giulia
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (08) : 802 - 807
  • [22] Preoperative lymph node staging in patients of non-small-cell lung cancer: accuracy of 18F-FDG PET/CT
    Wu, C. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S424 - S424
  • [23] Predictive value of 18F-FDG PET/CT based metabolic parameters in patients with non-small cell lung cancer treated with stereotactic body radiation therapy
    Garcia Belaustegui, L.
    Alcantara, M.
    Couto Caro, R.
    Garcia Garcia-Esquinas, M.
    Corona, J.
    Carreras Delgado, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S65 - S65
  • [24] 18F-FDG PET-CT SIMULATION FOR NON-SMALL-CELL LUNG CANCER: EFFECT IN PATIENTS ALREADY STAGED BY PET-CT
    Hanna, Gerard G.
    McAleese, Jonathan
    Carson, Kathryn J.
    Stewart, David P.
    Cosgrove, Vivian P.
    Eakin, Ruth L.
    Zatari, Ashraf
    Lynch, Tom
    Jarritt, Peter H.
    Young, V. A. Linda
    O'Sullivan, Joe M.
    Hounsell, Alan R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (01): : 24 - 30
  • [25] Role of various semiquantitative parameters of 18F-FDG PET/CT studies for interim treatment response evaluation in non-small-cell lung cancer
    Sharma, Akshima
    Mohan, Anant
    Bhalla, Ashu Seith
    Vishnubhatla, Sreenivas
    Pandey, Anil Kumar
    Bal, Chandra Sekhar
    Kumar, Rakesh
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (10) : 858 - 867
  • [26] The Role of Metabolic Parameters of Pre-treatment 18F-FDG PET/CT in Patients with Locally Advanced Cervical Cancer
    Wang, D.
    Hou, X.
    Hu, K.
    Zhang, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E497 - E498
  • [27] Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer
    Micco, Maura
    Vargas, Hebert Alberto
    Burger, Irene A.
    Kollmeier, Marisa A.
    Goldman, Debra A.
    Park, Kay J.
    Abu-Rustum, Nadeem R.
    Hricak, Hedvig
    Sala, Evis
    EUROPEAN JOURNAL OF RADIOLOGY, 2014, 83 (07) : 1169 - 1176
  • [28] Prognostic and Predictive Values of Metabolic Parameters of 18F-FDG PET/CT in Patients With Non-Small Cell Lung Cancer Treated With Chemotherapy
    Li, Xueyan
    Wang, Dawei
    Yu, Lijuan
    MOLECULAR IMAGING, 2019, 18
  • [29] Prognostic value of primary tumor SUVmax on pre-treatment 18F-FDG PET/CT imaging in patients with stage III non-small cell lung cancer
    Yilmaz, U.
    Batum, O.
    Koparal, H.
    Ozbilek, E.
    Kirakli, E.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2018, 37 (04): : 218 - 222
  • [30] Necrosis on pre-radiotherapy 18F-FDG PET/CT is a predictor for complete metabolic response in patients with non-small cell lung cancer
    Eren, Gulnihan
    Kupik, Osman
    MEDICINE, 2022, 101 (20)